Pathogens in Nosocomial Infections: Epidemiology, Resistance, and Control Measures

Year : 2025 | Volume : 02 | Issue : 01 | Page : 12 16
    By

    Tahseen Khan,

  1. Researcher, Dr. B.R. Ambedkar Center for Biomedical Research (ACBR),University of Delhi, New Delhi-110007, India

Abstract

Nosocomial infections, also known as healthcare-associated infections (HAIs), are a serious global health issue, leading to higher patient morbidity, prolonged hospital stays, and increased medical costs. Various pathogens—such as bacteria, viruses, fungi, and parasites—are responsible for these infections, especially in healthcare environments where they easily spread. They can be transmitted through direct contact with infected patients, contaminated medical equipment, or even airborne particles.Patients with weakened immune systems, those requiring prolonged hospitalization, and individuals using invasive devices like catheters and ventilators are especially vulnerable. One of the biggest challenges in treating HAIs is the growing problem of antimicrobial resistance (AMR). Pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) and Carbapenem- resistant Enterobacteriaceae (CRE) have developed resistance mechanisms like beta-lactamase production, efflux pumps, biofilm formation, and genetic mutations that make antibiotics less effective. The overuse and misuse of antibiotics in hospitals further accelerate this resistance, leaving fewer treatment options and increasing the risk of complications. To prevent healthcare-associated infections (HAIs), medical facilities need to enforce strict infection control practices. This includes thorough hand hygiene, responsible use of antibiotics, regular monitoring for infections, and proper sterilization of medical tools and equipment.Isolation protocols and environmental disinfection also play a key role. Additionally, researchers are exploring innovative treatments like bacteriophage therapy and probiotics. A team-based approach involving medical staff, microbiologists, and public health officials is essential to effectively prevent and manage HAIs.

Keywords: Nosocomial infections,Antimicrobial resistance (AMR),Healthcare-associated infections (HAIs),Infection control measures,Methicillin-resistant Staphylococcus aureus (MRSA).

[This article belongs to International Journal of Pathogens ]

How to cite this article:
Tahseen Khan. Pathogens in Nosocomial Infections: Epidemiology, Resistance, and Control Measures. International Journal of Pathogens. 2025; 02(01):12-16.
How to cite this URL:
Tahseen Khan. Pathogens in Nosocomial Infections: Epidemiology, Resistance, and Control Measures. International Journal of Pathogens. 2025; 02(01):12-16. Available from: https://journals.stmjournals.com/ijpg/article=2025/view=203754


References

  1. Weber DJ, Rutala WA. Nosocomial infections: prevention and control. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier; 2015. pp. 3294–330.
  2. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–6.
  3. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33.
  4. Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51.
  5. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–81.
  6. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160–201.
  7. Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337–418.
  8. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–33.
  9. Pittet D. Hand hygiene: improved standards and practice for hospital care. Curr Opin Infect Dis. 2003;16(4):327–35.
  10. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.
  11. Halpin H, Shortell SM. Using clinical practice guidelines and provider feedback to improve quality of care: results from a pilot study. Am J Med Qual. 2002;17(4):155–61.
  12. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.
  13. Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001;45(3):649–59.
  14. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7(9):503–14.
  15. World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 28/02/2025
Accepted 07/03/2025
Published 11/03/2025
Publication Time 11 Days
135

Login


My IP

PlumX Metrics